NDC 50881-010 – Jakafi
Ruxolitinib 10 mg/1 · Tablet · Oral
Product NDC50881-010
Product details
- Brand name
- Jakafi
- Generic name
- Ruxolitinib
- Labeler
- Incyte Corporation
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA202192
- Marketed since
- November 16, 2011
- Listing expires
- December 31, 2027
- Pharmacologic class
- Janus Kinase Inhibitor; Kinase Inhibitor
Active ingredients
- Ruxolitinib 10 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 50881-010-01 | 28 TABLET in 1 BOTTLE, PLASTIC (50881-010-01) | Nov 16, 2011 |
| 50881-010-60 | 60 TABLET in 1 BOTTLE, PLASTIC (50881-010-60) | Nov 16, 2011 |